Fluorotryptophane

Fluorotryptophane

SCHEMBL29623154

N[C@H](Cc1c[nH]c2ccc(F)cc12)C(=O)O

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 4/20 0.73
KMT2A Q03164 4/20 0.73
TSHR P16473 3/20 0.73
SLC6A4 P31645 3/20 0.73
KDM4E B2RXH2 2/20 0.73
LMNA P02545 2/20 0.73
MAPT P10636 2/20 0.73
HTR2C P28335 2/20 0.73
BLM P54132 2/20 0.73
PMP22 Q01453 2/20 0.73
HTR1A P08908 2/20 0.73
ALDH1A1 P00352 1/20 0.73
CYP3A4 P08684 1/20 0.73
ADORA3 P0DMS8 1/20 0.73
ALOX15 P16050 1/20 0.73
NFKB1 P19838 1/20 0.73
HTR7 P34969 1/20 0.73
HTR2B P41595 1/20 0.73
MTOR P42345 1/20 0.73
NPSR1 Q6W5P4 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fluorotryptophane SCHEMBL125000 1.00 HTR2A (0.73) HTR2AKMT2ATSHRSLC6A4KDM4E
Fluorotryptophane SCHEMBL29623254 1.00 HTR2A (0.73) HTR2AKMT2ATSHRSLC6A4KDM4E
Fluorotryptophane SCHEMBL29358068 1.00 HTR2A (0.73) HTR2AKMT2ATSHRSLC6A4KDM4E
Fluorotryptophane SCHEMBL122142 1.00 HTR2A (0.73) HTR2AKMT2ATSHRSLC6A4KDM4E
Fluorotryptophane SCHEMBL249955 1.00 HTR2A (0.73) HTR2AKMT2ATSHRSLC6A4KDM4E
Fluorotryptophane SCHEMBL18301531 0.94 KMT2A (0.78) HTR2AKMT2ATSHRSLC6A4KDM4E
Fluorotryptophane SCHEMBL18301535 0.94 KMT2A (0.78) HTR2AKMT2ATSHRSLC6A4KDM4E
SCHEMBL248870 0.89 KMT2A (0.66) HTR2AKMT2ATSHRSLC6A4KDM4E
SCHEMBL2330930 0.89 KMT2A (0.66) HTR2AKMT2ATSHRSLC6A4KDM4E
SCHEMBL7331236 0.89 HTR2A (0.66) HTR2AKMT2ATSHRSLC6A4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240400499-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2024-12-05 US claimed
US-12448398-B2 Semi-synthetic analogues of epipolythiodioxopiperazine alkaloids OHIO STATE INNOVATION FOUNDATION (US) 2025-10-21 US disclosed
US-20240400499-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2024-12-05 US disclosed
US-20220235072-A1 SEMI-SYNTHETIC ANALOGUES OF EPIPOLYTHIODIOXOPIPERAZINE ALKALOIDS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2022-07-28 US disclosed
EP-3986414-A1 SEMI-SYNTHETIC ANALOGUES OF EPIPOLYTHIODIOXOPIPERAZINE ALKALOIDS Ohio State Innovation Foundation (US) 2022-04-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12448398-B2 Semi-synthetic analogues of epipolythiodioxopiperazine alkaloids EHMT1, EHMT2, KMT5A HTR2A 2577/4885KMT2A 7/4885TSHR 4178/4885
US-20220235072-A1 SEMI-SYNTHETIC ANALOGUES OF EPIPOLYTHIODIOXOPIPERAZINE ALKALOIDS EHMT1, EHMT2, KMT5A HTR2A 2577/4885KMT2A 7/4885TSHR 4178/4885
US-20240400499-A1 NOVEL AMINO ACID DERIVATIVES BCAT1, BCAT2, PELP1 HTR2A 2719/4885KMT2A 3415/4885TSHR 2791/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.